268 Appendices 98. J.L. Ebenau: From subjective to objective cognitive decline: Using biomarkers to understand the earliest stages of Alzheimer’s disease (04-10-2022) 99. H. Ulugut Erkoyun: Challenges in phenotyping the frontotemporal dementia subtypes (08-11-2022) (Cum Laude) 100. M.A. Dubbelman: For good measure: Detecting and defining changes in everyday functioning in Alzheimer’s disease and related disorders (15-11-2022) 101. K.E.J. Wesenhagen: Alzheimer’s disease pathophysiology: Investigating biological heterogeneity in cerebrospinal fluid (06-02-2023) 102. S. Ingala: Before sunset: imaging Alzheimer’s disease in its earliest stages (17-05-2023) 103. M. Scarioni: Clinicopathological correlations in frontotemporal dementia (12-09-2023) 104. M. Muurling: Remote assessment of functional ability in Alzheimer’s disease (25-09-2023) 105. E.M. Coomans: Imaging tau pathology using PET: towards a better understanding of Alzheimer’s disease pathophysiology and clinical implementation (16-10-2023) 106. D. Visser: Optimizing the use of dynamic tau PET in Alzheimer’s Disease: methodological and clinical applications (23-01-2024)
RkJQdWJsaXNoZXIy MjY0ODMw